Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114944) titled 'The value of PSMA PET/CT in guiding the exemption of pelvic lymph node dissection in intermediate-risk prostate cancer patients: an observational study' on Dec. 19, 2025.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The Third Affiliated Hospital Sun Yat-sen University
Condition:
Intermediate-risk prostate cancer patients
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-23
Target Sample Size: Intermediate-risk prostate cancer patients group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=...